SELLAS Life Sciences (SLS) Treasury Shares (2010 - 2017)
SELLAS Life Sciences (SLS) posted quarterly Treasury Shares of $3.8 million for Q3 2017, little changed year-over-year from $3.8 million in Q3 2016, and little changed quarter-over-quarter from $3.8 million in Q2 2017.
Analysis
SELLAS Life Sciences (SLS) Treasury Shares (2010 - 2017) Analysis & Trends
SELLAS Life Sciences (SLS) has reported Treasury Shares for 8 consecutive years, with $3.8 million the latest figure, recorded in Q3 2017.
- In Q3 2017, Treasury Shares changed 0.0% year-over-year to $3.8 million; the TTM figure through Sep 2017 stood at $3.8 million (changed 0.0% YoY), while the FY2016 annual figure was $3.8 million, changed 0.0% from the prior year.
- Treasury Shares steadied at $3.8 million in Q3 2017 per SLS's latest filing, from $3.8 million in the prior quarter.
- Across five years, Treasury Shares topped out at $2.3 million in Q1 2026 and bottomed at $255000.0 in Q4 2022.
- Historically, Treasury Shares has averaged $799411.8 across 5 years, with a median of $472000.0 in 2024.
- On a YoY basis, Treasury Shares climbed as much as 0.0% in 2013 and fell as far as 0.0% in 2013.
- SELLAS Life Sciences' Treasury Shares stood at $3.8 million in 2013, then changed by 0.0% to $3.8 million in 2014, then changed by 0.0% to $3.8 million in 2015, then changed by 0.0% to $3.8 million in 2016, then changed by 0.0% to $3.8 million in 2017.
- Business Quant data shows SLS's Treasury Shares at $3.8 million in Q3 2017, $3.8 million in Q2 2017, and $3.8 million in Q1 2017.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 2.72 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | SELLAS Life Sciences | 2.62 Bn | 2.62 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2017 | 33,750.00 |
| Sep 30, 2017 | 3.85 Mn |
| Sep 30, 2017 | 3.85 Mn |
| Sep 30, 2017 | 33,750.00 |
| Jun 30, 2017 | 33,750.00 |
| Jun 30, 2017 | 3.85 Mn |
| Jun 30, 2017 | 3.85 Mn |
| Jun 30, 2017 | 33,750.00 |
| Mar 31, 2017 | 3.85 Mn |
| Mar 31, 2017 | 675,000.00 |
| Mar 31, 2017 | 675,000.00 |
| Mar 31, 2017 | 3.85 Mn |
| Dec 31, 2016 | 3.85 Mn |
| Dec 31, 2016 | 33,750.00 |
| Dec 31, 2016 | 33,750.00 |
| Dec 31, 2016 | 3.85 Mn |
| Sep 30, 2016 | 3.85 Mn |
| Sep 30, 2016 | 3.85 Mn |
| Sep 30, 2016 | 675,000.00 |
| Sep 30, 2016 | 675,000.00 |